These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25041074)

  • 21. Endoscopic retrograde cholangiopancreatography-related adverse events: general overview.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):97-106. PubMed ID: 25442961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications after ERCP in liver transplant recipients.
    Balderramo D; Bordas JM; Sendino O; Abraldes JG; Navasa M; Llach J; Cardenas A
    Gastrointest Endosc; 2011 Aug; 74(2):285-94. PubMed ID: 21704993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERCP with cholangiopancreatoscopy may be associated with higher rates of complications than ERCP alone: a single-center experience.
    Sethi A; Chen YK; Austin GL; Brown WR; Brauer BC; Fukami NN; Khan AH; Shah RJ
    Gastrointest Endosc; 2011 Feb; 73(2):251-6. PubMed ID: 21106195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis.
    Ludvigsson JF; Bergquist A; Ajne G; Kane S; Ekbom A; Stephansson O
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):95-100.e1. PubMed ID: 23891928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features.
    Kubota K; Kato S; Akiyama T; Yoneda M; Fujita K; Ogawa M; Inamori M; Kobayashi N; Saito S; Kakuta Y; Ohshiro H; Nakajima A
    Gastrointest Endosc; 2008 Dec; 68(6):1204-8. PubMed ID: 19028233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients.
    Hori Y; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Umemura S; Ban T; Okumura F; Sano H; Takada H; Joh T
    J Gastroenterol Hepatol; 2014 Mar; 29(3):648-52. PubMed ID: 23869844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
    Masci E; Mariani A; Curioni S; Testoni PA
    Endoscopy; 2003 Oct; 35(10):830-4. PubMed ID: 14551860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatitis potentially associated drugs as a risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective cohort study.
    Sigounas DE; Christodoulou DK; Tatsioni A; Katsanos KH; Baltayiannis G; Kappas A; Ioannidis JP; Tsianos EV
    Pancreas; 2013 May; 42(4):601-6. PubMed ID: 23548878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic ductal morphology and exocrine function in primary sclerosing cholangitis.
    Lindström E; Bodemar G; Rydén BO; Ihse I
    Acta Chir Scand; 1990; 156(6-7):451-6. PubMed ID: 2368550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
    Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
    Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERCP-guided cholangioscopy using a single-use system: nationwide register-based study of its use in clinical practice.
    Lübbe J; Arnelo U; Lundell L; Swahn F; Törnqvist B; Jonas E; Löhr JM; Enochsson L
    Endoscopy; 2015 Sep; 47(9):802-7. PubMed ID: 25910063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.
    Ito K; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Koshita S; Kanno Y; Ogawa T; Masu K; Hashimoto S
    Dig Endosc; 2014 May; 26(3):442-9. PubMed ID: 23937334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis.
    Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Butt M; Sanaka MR; Vargo JJ; Parsi MA
    Gastrointest Endosc; 2013 Jul; 78(1):81-90. PubMed ID: 23528654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP.
    Nakai Y; Isayama H; Sasahira N; Kogure H; Sasaki T; Yamamoto N; Saito K; Umefune G; Akiyama D; Kawahata S; Matsukawa M; Saito T; Hamada T; Takahara N; Mizuno S; Miyabayashi K; Mohri D; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2015 Jan; 81(1):119-26. PubMed ID: 25442080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study.
    Li J; Hu J; Li P; Wu Y; Wang Y; Ji M; Hua H; Ran W; Pan Y; Zhang S
    Chin Med J (Engl); 2022 Oct; 135(19):2319-2325. PubMed ID: 36103988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary sclerosing pancreatitis and cholangitis.
    Kazumori H; Ashizawa N; Moriyama N; Arima N; Hirakawa K; Adachi K; Watanabe M; Kinoshita Y; Tamura K
    Int J Pancreatol; 1998 Oct; 24(2):123-7. PubMed ID: 9816546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.